Leukocyte Telomere Length in the Finnish Diabetes Prevention Study
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Leukocyte telomere length (TL) is considered a biomarker for biological aging. Shortened TL has been observed in many complex diseases, including type 2 diabetes (T2DM). Lifestyle intervention studies, e.g. the Diabetes Prevention Study (DPS), have shown a decrease in the incidence of T2DM by promoting healthy lifestyles in individuals with impaired glucose tolerance (IGT). Our aim was to study in the DPS the influence of the lifestyle intervention on TL. TL was measured by quantitative PCR-based method at two time points (N = 334 and 343) on average 4.5 years apart during the active intervention and post-intervention follow-up. TL inversely correlated with age. Our main finding was that TL increased in about two thirds of the individuals both in the intervention and in the control groups during follow-up; TL increased most in individuals with the shortest TL at the first measurement. TL was not associated with development of T2DM, nor did lifestyle intervention have an effect on TL. No association between insulin secretion or insulin resistance indices and TL was observed. We did not detect an association between TL and development of T2DM in the DPS participants. It could be due to all participants being overweight and having IGT at baseline, both of which have been found to be independently associated with shorter leukocyte TL in some earlier studies. TL had no substantial role in worsening of glucose tolerance in people with IGT. Our study confirms that leukocyte TL can increase with time even in obese people with impaired glucose metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 16×
“Glucose and Insulin Measurements Glucose levels were measured locally by standard methods, and the measurements were standardized by the central laboratory in Helsinki [31].”
BackgroundMethodInfluentialSelf-citationThe Finnish Diabetes Prevention Study (DPS)
Lindström, J., Louheranta, A., Mannelin, M., Rastas, M., Salminen, V., Eriksson, J., Uusitupa, M., Tuomilehto, J., & for the Finnish Diabetes Prevention Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3230 · Cited by 1,848 · cited 11×
“We did not detect an association between TL and development of T2DM in the DPS participants.”
BackgroundMethodInfluentialSelf-citationLindström, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J. G., Hemiö, K., Hämäläinen, H., Härkönen, P., Keinänen-Kiukaanniemi, S., Laakso, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69701-8 · Cited by 1,799 · cited 1×
“For this purpose, individuals already diagnosed with T2DM according to WHO criteria [31,34] at the beginning of each follow-up were excluded from the analyses.”
MethodSelf-citationObesity, cigarette smoking, and telomere length in women
Valdes, A., Andrew, T., Gardner, J., Kimura, M., Oelsner, E., Cherkas, L., Aviv, A., & Spector, T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66630-5 · Cited by 1,363 · cited 2×
“TL is a complex phenotype affected by genes [10–13] and environmental factors, such as smoking [14] and physical activity [15].”
BackgroundLeukocyte Telomere Length and Cardiovascular Disease in the Cardiovascular Health Study
Fitzpatrick, A. L., Kronmal, R. A., Gardner, J. P., Psaty, B. M., Jenny, N. S., Tracy, R. P., Walston, J., Kimura, M., & Aviv, A. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj346 · Cited by 773 · cited 1×
“diseases [16,17].”
Clarke, P. M., Gray, A. M., Briggs, A., Farmer, A. J., Fenn, P., Stevens, R. J., Matthews, D. R., Stratton, I. M., Holman, R. R., & on behalf of the UK Prospective Diabetes Study (UKPDS) Group (2004) · Diabetologia · doi:10.1007/s00125-004-1527-z · Cited by 615 · cited 1×
“T2DM is known to shorten life expectancy compared with the general population, mostly due to cardiovascular diseases [18,19].”
BackgroundIncreased telomerase activity and comprehensive lifestyle changes: a pilot study
Ornish, D., Lin, J., Daubenmier, J., Weidner, G., Epel, E., Kemp, C., Magbanua, M. J. M., Marlin, R., Yglecias, L., Carroll, P. R., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70234-1 · Cited by 430 · cited 2×
“[29] recently showed in men with benign prostate cancer that a three-month intensive lifestyle change, consisting of healthier diet, moderate aerobic exercise, stress management, and group support sessions, increased telomerase activity in peripheral blood mononuclear cells.”
BackgroundFranco, O. H., Steyerberg, E. W., Hu, F. B., Mackenbach, J., & Nusselder, W. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.11.1145 · Cited by 400 · cited 1×
“T2DM is known to shorten life expectancy compared with the general population, mostly due to cardiovascular diseases [18,19].”
BackgroundCommon variants near TERC are associated with mean telomere length
Wellcome Trust Case Control Consortium, Codd, V., Mangino, M., van der Harst, P., Braund, P. S., Kaiser, M., Beveridge, A. J., Rafelt, S., Moore, J., Nelson, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.532 · Cited by 344
Kananen, L., Surakka, I., Pirkola, S., Suvisaari, J., Lönnqvist, J., Peltonen, L., Ripatti, S., & Hovatta, I. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010826 · Cited by 270 · cited 1×
“The relative telomere length was determined from DNA by a quantitative real-time PCR-based method [32,33] with the following modifications.”
MethodMapping of a Major Locus that Determines Telomere Length in Humans
Vasa-Nicotera, M., Brouilette, S., Mangino, M., Thompson, J. R., Braund, P., Clemitson, J.-R., Mason, A., Bodycote, C. L., Raleigh, S. M., Louis, E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/426734 · Cited by 257
Blood Cell Telomere Length Is a Dynamic Feature
Svenson, U., Nordfjäll, K., Baird, D., Roger, L., Osterman, P., Hellenius, M.-L., & Roos, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021485 · Cited by 132 · cited 2×
“feature and that TL can vary to both directions during a lifetime [9].”
Background
Cited by
Ornish, D., Lin, J., Chan, J. M., Epel, E., Kemp, C., Weidner, G., Marlin, R., Frenda, S. J., Magbanua, M. J. M., Daubenmier, J., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70366-8 · Cited by 390
D’Mello, M. J. J., Ross, S. A., Briel, M., Anand, S. S., Gerstein, H., & Paré, G. (2015) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.113.000485 · Cited by 350
Willeit, P., Raschenberger, J., Heydon, E. E., Tsimikas, S., Haun, M., Mayr, A., Weger, S., Witztum, J. L., Butterworth, A. S., Willeit, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112483 · Cited by 211
“We carefully checked the full-text of the remaining 19 records and excluded a further 17 articles, including 12 case-control studies and 1 study that selectively recruited participants with impaired glucose tolerance [44].”
MethodDimauro, I., Sgura, A., Pittaluga, M., Magi, F., Fantini, C., Mancinelli, R., Sgadari, A., Fulle, S., & Caporossi, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-04448-4 · Cited by 47
Rosa, E. C. C. C., dos Santos, R. R. C., Fernandes, L. F. A., Neves, F. D. A. R., Coelho, M. S., & Amato, A. A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.10.020 · Cited by 28
Metadata
- Authors
- Hovatta, I., de Mello, V. D. F., Kananen, L., Lindström, J., Eriksson, J. G., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Peltonen, M., Tuomilehto, J., & Uusitupa, M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-04-06
- Volume
- 7
- Issue
- 4
- Pages
- e34948
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2042847509
- Cited by
- 79
- References
- 12
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.